Effects of Angiotensin II on Liver Blood Flow
Author Information
Author(s): E. Leen, W.J. Angerson, H.W. Warren, J.A. Goldberg, G.R. Sutherland, T.G. Cooke, C.S McArdle
Primary Institution: University Department of Surgery, Royal Infirmary, Glasgow, Scotland, UK
Hypothesis
The study aims to evaluate the effects of angiotensin II infusion on hepatic arterial blood flow and resistance in patients with intrahepatic tumors.
Conclusion
Duplex/colour Doppler sonography is effective in assessing changes in hepatic arterial blood flow caused by angiotensin II infusion.
Supporting Evidence
- Hepatic arterial blood flow was significantly reduced by 70-80% within 30 seconds of angiotensin II infusion in patients with less than 30% hepatic replacement by tumors.
- In patients with over 50% hepatic replacement, blood flow increased by 2-2.5 times the baseline level during angiotensin II infusion.
Takeaway
This study looked at how a medicine called angiotensin II affects blood flow in the liver of patients with liver tumors, showing that it can change blood flow significantly.
Methodology
Hepatic arterial blood flow was measured in nine patients using duplex/colour Doppler sonography before, during, and after an infusion of angiotensin II.
Limitations
The study's findings may not be generalizable due to the small sample size and specific patient demographics.
Participant Demographics
Patients aged 48-69 years with colorectal liver metastases.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website